| 查看: 761 | 回复: 3 | |||
| 当前主题已经存档。 | |||
[交流]
Alkermes是一家什么公司
|
|||
|
请问各位大虾,Alkermes是一家什么公司啊?中文名叫什么喔,它在中国有销售处没有啊?主要生产什么呢? 谢谢各位啦!!! |
» 猜你喜欢
国家基金申请书模板内插入图片不可调整大小?
已经有9人回复
退学或坚持读
已经有20人回复
免疫学博士有名额,速联系
已经有14人回复
面上基金申报没有其他的参与者成吗
已经有4人回复
多组分精馏求助
已经有6人回复
国家级人才课题组招收2026年入学博士
已经有6人回复

★
karl2100(金币+1,VIP+0):多谢提供!
karl2100(金币+1,VIP+0):多谢提供!
|
基本资料 Alkermes, Inc. 88 Sidney Street Cambridge, MA 02139-4136 电话: 617-494-0171 传真: 617-494-9263 网站: http://www.alkermes.com Alkermes, Inc., a biotechnology company, develops products based on proprietary, extended-release and pulmonary drug delivery technologies. It has two commercial products that include RISPERDAL CONSTA, a long-acting atypical antipsychotic medication approved for use in schizophrenia, marketed worldwide by Janssen-Cilag; and VIVITROL, a once-monthly injectable medication approved for the treatment of alcohol dependence, marketed in the U.S. primarily by Cephalon, Inc. The company's pipeline comprises extended-release injectable, pulmonary, and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, addiction, and diabetes. Its development programs also include AIR Insulin, which is in Phase III clinical development stage for the treatment of diabetes; Exenatide LAR, a Phase II clinical development stage product for the treatment of type 2 diabetes; a Phase I/II clinical study product, ALKS 29, for the treatment of alcohol dependence; a Phase IIa clinical study product, ALKS 27, for the treatment of COPD, which is a serious, chronic disease characterized by a gradual loss of lung function; and AIR parathyroid hormone, a Phase I clinical study product for the treatment of osteoporosis. In addition, the company has an early-stage pipeline focused on various disease areas. Alkermes has collaborations with Eli Lilly and Company; Amylin Pharmaceuticals, Inc.; Cephalon, Inc.; Indevus Pharmaceuticals, Inc.; and Janssen-Cilag. The company was founded in 1987 and is headquartered in Cambridge, Massachusetts. |
2楼2008-05-07 23:00:40

3楼2008-05-08 16:24:00
4楼2008-07-13 21:59:58













回复此楼
